Propylthiouracil (PTU) side effects

The FDA warned prescribers about the risk of serious liver injury associated with the use of the anti-thyroid drug propylthiouracil (PTU).
FDA’s warning highlights:
There is an increased risk of liver injury with propylthiouracil (PTU) when compared to methimazole.
Monitor for symptoms and signs of liver injury when propylthiouracil is chosen as anti-thyroid therapy. This should be emphasized during the first six months after initiating therapy.

Comments

Popular posts from this blog

Treatment Guidelines for Malaria Contd...

Acute migraine treatments

EFFECT OF ACETAMINOPHEN ON BLOOD PRESSURE